NCT03596944View on ClinicalTrials.gov

Primary Prevention With Statin and Incidence of Recurrent MI and Cardiogenic Shock in Post-ACS Patients

CompletedOBSERVATIONAL

Enrollment

145

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

June 30, 2018

Study Completion Date

August 31, 2018

Conditions

Acute Coronary SyndromeRecurrent Myocardial InfarctionCardiogenic Shock

Interventions

DRUG

Statin

Prescribed with statins for primary prevention

Trial Locations (1)

Unknown

Cengkareng General Hospital, Jakarta

All Listed Sponsors

collaborator

Cengkareng General Hospital

OTHER

lead

Tarumanagara University

OTHER

NCT03596944 - Primary Prevention With Statin and Incidence of Recurrent MI and Cardiogenic Shock in Post-ACS Patients | Biotech Hunter | Biotech Hunter